title: Impact of genomic aberrations including chromosome 1 abnormalities on the outcome of patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone.
authors.affiliation: Department of Laboratory Hematology, University Health Network, Toronto, Canada. Hong.Chang@uhn.on.ca
authors.forename: Hong
authors.initials: H
authors.lastname: Chang
authors.forename: Allan
authors.initials: A
authors.lastname: Jiang
authors.forename: Connie
authors.initials: C
authors.lastname: Qi
authors.forename: Young
authors.initials: Y
authors.lastname: Trieu
authors.forename: Christine
authors.initials: C
authors.lastname: Chen
authors.forename: Donna
authors.initials: D
authors.lastname: Reece